Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Features
FeesSafety
Academy
More
Pluang+

Compare AKR Corporindo Tbk (AKRA) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

AKR Corporindo Tbk
Brigit Biofarmaka Teknologi Tbk.

Price performance

Price movement over the last 24 hours

Key statistics

AKR Corporindo Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? AKR Corporindo Tbk trades at Rp1,320 (market cap 26T, 15.27M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp242 (market cap 160.57B, 2.51M 24h volume). The key difference: AKR Corporindo Tbk is far larger — about 161.9× Brigit Biofarmaka Teknologi Tbk.'s market cap, and AKR Corporindo Tbk is more actively traded (15.27M versus 2.51M). Which is the better fit depends on your goals.

AKRAOBAT
Market Cap
26T160.57B
Volume
15.27M2.51M
Lot
152.7K25.09K
Turnover
20.11B636.74M
Average Price
1,316.87253.78
Value
20.11B636.74M
Indicative Equilibrium Price
1,320242
Indicative Equilibrium Volume
4.56K146

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

AKRA
View details
OBAT
View details

About AKR Corporindo Tbk

PT AKR Corporindo Tbk was established in Surabaya on November 28, 1977 based on the Notarial Deed No. 46 of Sastra Kosasih, S.H., which was amended by Notarial Deed No. 26 of the same notary dated April 12, 1978 . In 2004, the Company changed its name from PT Aneka Kimia Raya Tbk to PT AKR Corporindo Tbk. PT Aneka Kimia Raya is the largest chemical distributor in Indonesia. The Company is dominantly positioned within the industry, distributing more than 40 chemical products. The Company is foreign investment.

Read more on AKRA

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT